ESR1 and breast cancer: A study by Perou et al. first classified BC into four distinct subtypes: luminal A and luminal B, which overexpress the oestrogen receptor (ER), human epidermal growth factor receptor 2 (HER2)-enriched and basal-like or triple-negative [5] (Figure 1).